Regulation of nitric oxide production in hypothyroidism.

Zoran M Gluvic, Milan M Obradovic, Emina M Sudar-Milovanovic, Sonja S Zafirovic, Djordje J Radak, Magbubah M Essack, Vladimir B. Bajic, Takashi Gojobori, Esma R Isenovic

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Hypothyroidism is a common endocrine disorder that predominantly occurs in females. It is associated with an increased risk of cardiovascular diseases (CVD), but the molecular mechanism is not known. Disturbance in lipid metabolism, the regulation of oxidative stress, and inflammation characterize the progression of subclinical hypothyroidism. The initiation and progression of endothelial dysfunction also exhibit these changes, which is the initial step in developing CVD. Animal and human studies highlight the critical role of nitric oxide (NO) as a reliable biomarker for cardiovascular risk in subclinical and clinical hypothyroidism. In this review, we summarize the recent literature findings associated with NO production by the thyroid hormones in both physiological and pathophysiological conditions. We also discuss the levothyroxine treatment effect on serum NO levels in hypothyroid patients.
Original languageEnglish (US)
Pages (from-to)109881
JournalBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
StatePublished - Jan 24 2020


Dive into the research topics of 'Regulation of nitric oxide production in hypothyroidism.'. Together they form a unique fingerprint.

Cite this